The use of low doses of psychedelic substances (microdosing) is attracting increasing
interest. This systematic review summarises all empirical microdosing research to date …

In recent years, psychedelic-assisted psychotherapies have reentered the realm of rigorous
scientific inquiry, garnering much attention from both the psychiatric community and the …

Key transformations in a four-step synthesis of the ergot alkaloid scaffold include a novel
cesium carbonate-mediated hydrogen autotransfer alkylation to generate the C (3)–C (4) …

Microdosing psychedelic drugs at a level below the threshold to induce hallucinations is an
increasingly common lifestyle practice. However, the effects of microdosing on sleep have …

Abstract With the Food and Drug Administration designation in 2017 of 3, 4-
methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic …

Psychedelics have shown promising effects in several psychiatric diseases as demonstrated
by multiple clinical trials. However, no clinical experiments on patients with schizophrenia …

Background An advanced cancer diagnosis can be associated with a significant profile of
distress. Psychedelic compounds have shown clinically significant effects in the treatment of …

Background Microdosing psychedelics is a phenomenon with claimed cognitive benefits that
are relatively untested clinically. Pre-clinically, psychedelics have demonstrated enhancing …

Introduction Enhanced creativity is often cited as an effect of microdosing (taking repeated
low doses of a psychedelic drug). There have been recent efforts to validate the reported …

Background: The applications of psilocybin, derived from 'magic mushrooms,'are vast,
including a burgeoning practice known as microdosing, which refers to the administration of …